Latest Financials News

Felix Gold is advancing its Treasure Creek Project in Alaska, aiming for the first domestic antimony concentrate production in over 30 years by late 2025 or early 2026, supported by strong government engagement and solid finances.

Actinogen Medical has reached a key milestone in its XanaMIA phase 2b/3 Alzheimer’s trial with over 100 participants enrolled, setting the stage for an interim analysis in January 2026. The company also secured a $13.8 million non-dilutive R&D funding facility to support ongoing development.

DroneShield Limited has reported record revenue growth in 2Q25, driven by soaring demand for AI-powered counterdrone solutions amid a global surge in defense spending. The company’s expanding $2.33 billion sales pipeline and strong cash position position it well for future growth.

Vitrafy Life Sciences reported robust progress in Q4 FY2025, advancing its cryopreservation technology and commercial partnerships while preparing for a pivotal product launch in FY2026.

Aeeris Ltd reported a strong Q4 FY25 with a 13.3% increase in annual recurring revenue, driven by the full deployment of its proprietary AWARE system and strategic in-house service transitions.

Jade Gas Holdings has secured a A$3.64 million director loan to advance production at its Red Lake Gas Field, anticipating a transformational gas breakthrough this quarter.

BrainChip Holdings reported a solid June quarter with $13.5 million in cash, increased customer inflows, and a strategic decision to remain listed on the ASX. The company advanced multiple commercial collaborations and expanded its intellectual property portfolio, signaling confidence in its edge AI technology roadmap.

Culpeo Minerals reported a challenging quarter ending June 2025 with net cash outflows from operations and investing activities, offset by a recent $2.49 million capital raise that underpins its near-term funding.

Avecho Biotechnology has ramped up recruitment in its pivotal Phase III insomnia trial and is advancing plans for regulatory approval and commercialization of its TPM®-enhanced CBD capsule, aiming to be the first over-the-counter CBD insomnia treatment in Australia.

HITIQ Ltd has launched its PROTEQT smart mouthguard for grassroots sports, secured a five-year exclusive global partnership with Shock Doctor, and raised $1.9 million to fund manufacturing and market growth.

Recharge Metals Limited has made significant progress in its uranium and copper projects, advancing permitting and drill planning in Montana while identifying promising sulphide targets in Western Australia.

Experience Co Limited has reported unaudited FY25 results showing solid revenue and underlying EBITDA growth, driven by strong demand in skydiving and adventure experiences despite some weather-related setbacks.